A critical assessment of the effects of tamsulosin and solifenacin as monotherapies and as a combination therapy for the treatment of ureteral stent-related symptoms: a 2 × 2 factorial randomized trial

World Journal of Urology

Volumn 33, Issue 11, 2015, Pages 1833-1840

  Park, Jinsung ^a   Yoo, Changhee ^b   Han, Deok Hyun ^c   Shin, Dong Wook ^d  

^a Eulji University School of Medicine   (South Korea)

^b Hallym University   (South Korea)

^c Samsung Medical Center   (South Korea)

^d Seoul National University Hospital   (South Korea)

Author keywords

Quality of life; Solifenacin; Tamsulosin; Ureteral calculi; Ureteral stent

Indexed keywords

SOLIFENACIN; SULFONAMIDE; TAMSULOSIN; URINARY TRACT AGENT;

ADVERSE EFFECTS; CLINICAL TRIAL; COMBINATION DRUG THERAPY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MULTICENTER STUDY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PROSPECTIVE STUDY; PROSTHESIS FAILURE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SOUTH KOREA; STENT; TIME FACTOR; TREATMENT OUTCOME; URETERAL CALCULI; URETEROSCOPY;

DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTHESIS FAILURE; QUALITY OF LIFE; REPUBLIC OF KOREA; SOLIFENACIN SUCCINATE; STENTS; SULFONAMIDES; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME; URETERAL CALCULI; URETEROSCOPY; UROLOGICAL AGENTS;

EID: 84945459057     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-015-1544-1     Document Type: Article

References (24)

1. Tolley D (2000) Ureteric stents, far from ideal. Lancet 356:872–873
2. Joshi HB, Newns N, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG (2003) Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol 169:1060–1064
3. Pollard SG, Macfarlane R (1988) Symptoms arising from double-J ureteral stents. J Urol 139:37–38
4. Deliveliotis C, Chrisofos M, Gougousis E, Papatsoris A, Dellis A, Varkarakis IM (2006) Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology 67:35–39
5. Beddingfield R, Pedro RN, Hinck B, Kreidberg C, Feia K, Monga M (2009) Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study. J Urol 181:170–176
6. Wang CJ, Huang SW, Chang CH (2009) Effects of specific alpha-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study. Urol Res 37:147–152
7. Park SC, Jung SW, Lee JW, Rim JS (2009) The effects of tolterodine extended release and alfuzosin for the treatment of double-J stent-related symptoms. J Endourol 23:1913–1917
8. Damiano R, Autorino R, De Sio M, Giacobbe A, Palumbo IM, D’Armiento M (2008) Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study. J Endourol 22:651–656
9. Wang CJ, Huang SW, Chang CH (2009) Effects of tamsulosin on lower urinary tract symptoms due to double-J stent: a prospective study. Urol Int 83:66–69
10. Navanimitkul N, Lojanapiwat B (2010) Efficacy of tamsulosin 0.4 mg/day in relieving double-J stent-related symptoms: a randomized controlled study. J Int Med Res 38:1436–1441
11. Mokhtari G, Shakiba M, Ghodsi S, Farzan A, Heidari Nejad S, Esmaeili S (2011) Effect of terazosin on lower urinary tract symptoms and pain due to double-J stent: a double-blind placebo-controlled randomized clinical trial. Urol Int 87:19–22
12. Lee YJ, Huang KH, Yang HJ, Chang HC, Chen J, Yang TK (2013) Solifenacin improves double-J stent-related symptoms in both genders following uncomplicated ureteroscopic lithotripsy. Urolithiasis 41:247–252
13. Lim KT, Kim YT, Lee TY, Park SY (2011) Effects of tamsulosin, solifenacin, and combination therapy for the treatment of ureteral stent related discomforts. Korean J Urol 52:485–488
14. Shalaby E, Ahmed AF, Maarouf A, Yahia I, Ali M, Ghobish A (2013) Randomized controlled trial to compare the safety and efficacy of tamsulosin, solifenacin, and combination of both in treatment of double-J stent-related lower urinary symptoms. Adv Urol 2013:752382
15. Lee SJ, Yoo C, Oh CY, Lee YS, Cho ST, Lee SH, Yang DY, Lee SK, Cho JS (2010) Stent Position is more important than alpha-blockers or anticholinergics for stent-related lower urinary tract symptoms after ureteroscopic ureterolithotomy: a prospective randomized study. Korean J Urol 51:636–641
16. Kuyumcuoglu U, Eryildirim B, Tuncer M, Faydaci G, Tarhan F, Ozgul A (2012) Effectiveness of medical treatment in overcoming the ureteral double-J stent related symptoms. Can Urol Assoc J 6:E234–E237
17. Norris RD, Sur RL, Springhart WP, Marguet CG, Mathias BJ, Pietrow PK, Albala DM, Preminger GM (2008) A prospective, randomized, double-blinded placebo-controlled comparison of extended release oxybutynin versus phenazopyridine for the management of postoperative ureteral stent discomfort. Urology 71:792–795
18. Jeon SS, Choi YS, Hong JH (2007) Determination of ideal stent length for endourologic surgery. J Endourol 21:906–910
19. Lee SW, Woo SH, Yoo DS, Park J (2014) Effect of tamsulosin on stone expulsion in proximal ureteral calculi: an open-label randomized controlled trial. Int J Clin Pract 68:216–221
20. Park J, Shin DW, Chung JH, Lee SW (2013) Shock wave lithotripsy versus ureteroscopy for ureteral calculi: a prospective assessment of patient-reported outcomes. World J Urol 31:1569–1574
21. Park J, Shin DW, You C, Chung KJ, Han DH, Joshi HB, Park HK (2012) Cross-cultural application of the korean version of ureteral stent symptoms questionnaire. J Endourol 26:1518–1522
22. The EuroQol Group (1990) EuroQol–a new facility for the measurement of health-related quality of life. Health Policy 16:199–208
23. Beiko DT, Watterson JD, Knudsen BE, Nott L, Pautler SE, Brock GB, Razvi H, Denstedt JD (2004) Double-blind randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms after extracorporeal shockwave lithotripsy. J Endourol 18:723–730
24. Yakoubi R, Lemdani M, Monga M, Villers A, Koenig P (2011) Is there a role for alpha-blockers in ureteral stent related symptoms? A systematic review and meta-analysis. J Urol 186:928–934